Cleared Traditional

K212817 - Merit Siege Vascular Plug

K212817 is an FDA 510(k) clearance for Merit Siege Vascular Plug, manufactured by Merit Medical System, Inc.. The device is a Class 2 Cardiovascular device with product code KRD cleared through the Traditional 510(k) pathway after a 103-day FDA review.

K212817 · Merit Medical System, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
103d
Days
Class 2
Risk

K212817 is an FDA 510(k) clearance for the Merit Siege Vascular Plug. Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Merit Medical System, Inc. (South Jordan, US). The FDA issued a Cleared decision on December 15, 2021 after a review of 103 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Merit Medical System, Inc. devices

FDA 510(k) Submission Details - K212817

510(k) Number K212817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2021
Decision Date December 15, 2021
Days to Decision 103 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 125d · This submission: 103d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRD Device Classification - Class 2, Special Controls

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 97
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K212817.
Prestige Coil System
K220699 · Bait USA, LLC · Apr 2022
Solus Gold Embolization Device
K213200 · Artio Medical, Inc. · Mar 2022
Endoluminal Occlusion System, EOS-X, Endoluminal Occlusion System, EOS
K212057 · Artventive Medical Group, Inc. · Mar 2022
HRSpheres Narrow-Size Embolic Microspheres
K210562 · Suzhou Hengrui Hongyuan Medical Co., Ltd. · Oct 2021
Concerto Versa, Detachable Coil
K202850 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Feb 2021
LOBO Vascular Occlusion System (model LOBO-5)
K203025 · Okami Medical · Nov 2020